Drug intelligence / Profile preview

68Ga-P16-093

Development stage: Phase 2
Lead developer: Five Eleven Pharma
Modality: Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration: Intravenous

Overview

68Ga-P16-093 is a radiopharmaceutical diagnostic agent used for positron emission tomography (PET) imaging. It consists of the positron-emitting radionuclide Gallium-68 (68Ga) conjugated to the P16-093 ligand, which specifically targets the Prostate-Specific Membrane Antigen (PSMA). PSMA is a transmembrane protein that is highly overexpressed in prostate cancer cells, making it an effective target for molecular imaging of primary and metastatic disease. Developed by researchers at the First Affiliated Hospital of Fujian Medical University, 68Ga-P16-093 is primarily investigated for the detection, staging, and diagnostic evaluation of newly diagnosed, treatment-naive prostate cancer. Clinical studies have focused on comparing its diagnostic efficacy with multi-parameter magnetic resonance imaging (mpMRI) to improve the accuracy of prostate cancer localization and characterization.

Brand names: gallium-68-labeled P16-093gallium68-labeled P16-093gallium 68-labeled P16-093
Other names: gallium Ga 68-P16-093[68Ga]Ga-P16-093

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on 68Ga-P16-093.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-P16-093.

Explore the full profile